Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03425279 |
|---|---|
| Brief Title: | Phase 2 CAB-AXL-ADC Safety and Efficacy Study in Adult and Adolescent Patients With Sarcoma |
| First Submitted : | January 22, 2018 |
| First Submitted that Met QC Criteria : | February 6, 2018 |
| First Posted : | February 7, 2018 |
| Last Update Submitted that Met QC Criteria : | September 7, 2021 |
| Last Update Posted : | September 13, 2021 |